News
SOPH
3.040
0.00%
0.000
SOPHiA GENETICS Announces Key Approvals at 2025 Annual General Meeting
TipRanks · 3d ago
SOPHiA GENETICS (SOPH) Gets a Buy from RBC Capital
TipRanks · 4d ago
Weekly Report: what happened at SOPH last week (0609-0613)?
Weekly Report · 5d ago
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today?
NASDAQ · 06/09 19:00
Weekly Report: what happened at SOPH last week (0602-0606)?
Weekly Report · 06/09 09:22
Weekly Report: what happened at SOPH last week (0526-0530)?
Weekly Report · 06/02 09:23
SOPHiA GENETICS (SOPH) Gets a Hold from Morgan Stanley
TipRanks · 05/27 12:27
Weekly Report: what happened at SOPH last week (0519-0523)?
Weekly Report · 05/26 09:23
Tracking Al Gore's Generation Investment Management Portfolio - Q1 2025 Update
Seeking Alpha · 05/26 00:57
Weekly Report: what happened at SOPH last week (0512-0516)?
Weekly Report · 05/19 09:22
SOPHiA GENETICS Releases 2024 ESG Impact Summary
TipRanks · 05/16 14:19
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
NASDAQ · 05/15 19:00
SOPHiA GENETICS Q1 2025 Earnings Call Highlights
TipRanks · 05/13 01:36
Weekly Report: what happened at SOPH last week (0505-0509)?
Weekly Report · 05/12 09:22
SOPHiA GENETICS to Hold Annual General Meeting Amidst Strategic Growth
TipRanks · 05/08 18:47
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 05/07 11:20
SOPHiA GENETICS Reports Strong Q1 2025 Growth
TipRanks · 05/07 04:40
Promising Growth and Market Expansion Justify Buy Rating for SOPHiA GENETICS
TipRanks · 05/06 19:15
SOPHiA Genetics GAAP EPS of -$0.26, revenue of $17.8M
Seeking Alpha · 05/06 12:39
SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 05/06 11:55
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.